Three Houston-based startups logged on to pitch digitally this week since SXSW was canceled. Getty Images

When SXSW canceled a couple weeks ago, event organizers were sent into a frantic scramble of how to salvage some aspect of their plans while also balancing lost deposits, canceled travel, and so much more.

Three pitch events associated with SXSW and featuring Houston startups went on in a digital capacity, and the social distancing has only just began. Michele Price who leads Startup Grind Houston says the Google-backed organization with locations everywhere is aware of the need for digital networking options.

"We are all going to be in some education training ourselves learning how to deliver value to our communities from the digital space," Price says during her video pitch conference call, "and how to take our face-to-face opportunities and events and work them over so that they can meet the needs of where we all are right now."

Here are the Houston companies who had to switch up their pitches for an online audience this week.

Footprint App takes 3rd place in Hatch Pitch

footprint

Climate change sparked a young Houstonian to create Footprint, an app that tracks a person's ecological impact. Photo courtesy of Footprint

On Monday, Houston-based Hatch Pitch was supposed to have its annual pitch competition from SXSW in Austin. Per usual, Hatch was going to stream the invite-only competition to online viewers. However, with SXSW being canceled, the program went completely online. The four entrepreneurs who were selected to pitch for the panel of judges presented online and each of the judges chimed in with questions and feedback.

The four startups that pitched were Los Angeles-based Mi Terra, Canada-based Byte Sight, New Jersey-based Well Power, and Houston-based Footprint. WellPower won first place, as well as the crowd award, Byte Sight took second and the audience award, and Footprint won third.

Dakota Stormer founded Footprint last year and said this was his first pitch competition. Footprint is an app that tracks the carbon footprints of users. It works similar to diet-tracking apps like MyFitnessPal, but it doesn't count the calories; instead, it logs the emissions of their eating and travel habits. Read more about Footprint here.

Hatch Pitch has plans to have a second pitch competition later next month focused on cybersecurity. It's, at the moment, still planned to take place in person at the Houston Cyber Summit.

For All Abilities pitches for Startup Grind Houston

for all abilities

Betsy Furler founded For All Abilities to use technology to support employees with disabilities. Photo courtesy of For All Abilities

With so many startups' plans to attend SXSW ruined, Startup Grind Houston planned an online pitch event. There weren't any prizes, but it was a good way to virtually network and share stories. Houston-based For All Abilities founder, Betsy Furler, explained her software company that aims to help businesses support employees with ADHD, Dyslexia, learning differences, and Autism.

The company, which launched in April 2019, was founded by Betsy Furler, who specializes in workplace disability issues. Furler created a strengths, needs, and preferences assessment to uncover the needs and preferences of employees to prescribe specific, individualized, inexpensive, and easy-to-use support.

Furler called for potential partners as she scales her growth.

"Ideal customer is the large companies who care about their employees," she says in her pitch, explaining that she thinks companies on the West Coast would be particularly interested.

Velour Imports presents for The Established's Startup of the Year competition

Velour Imports makes it easier for big resorts to get wholesale craft drinks. Pexels

The Established House has hosted a pitch competition every year at SXSW, and this year was no different — except that it went on online only. Fourteen companies from across the country pitched, including one Houston representative.

Velour Imports is a beverage wholesale marketplace that uses a similar concept as Uber Eats to connect resorts and hospitality clients to pallets of craft beer, wine, hard cider, and spirits from a digital menu and then watch orders arrive from any smartphone or web device. It's usually quite difficult to order craft beverages on a large scale, and Velour Imports provides that solution in an innovative, digital form.

"Luxury resorts and hotels have an annual challenge of creating exciting, new food and beverage experiences to attract guests," says founder Brooke Sinclair in her pitch, "but rarely do they have the time and resources to go shopping."

While Velour didn't win any of the top five spots in the competition, she did get positive feedback on her presentation.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Nominations are now open for the 2025 Houston Innovation Awards

Calling All Innovators

Calling all Houston innovators: The Houston Innovation Awards return this fall to celebrate the best and brightest in the Houston innovation ecosystem right now.

Presented by InnovationMap, the fifth annual Houston Innovation Awards will take place November 5 at TMC Helix Park.

The awards program will honor the top startups and innovators in Houston across 10 categories, and we're asking you to nominate the most deserving Houston innovators and innovative companies today.

This year's categories are:

  • Minority-founded Business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation.
  • Female-founded Business, honoring an innovative startup founded or co-founded by a woman.
  • Energy Transition Business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond.
  • Health Tech Business, honoring an innovative startup within the health and medical technology sectors.
  • Deep Tech Business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges, including those in the AI, robotics, and space sectors.
  • Startup of the Year (People's Choice), honoring a startup celebrating a recent milestone or success. The winner will be selected by the community via an interactive voting experience.
  • Scaleup of the Year, honoring an innovative later-stage startup that's recently reached a significant milestone in company growth.
  • Incubator/Accelerator of the Year, honoring a local incubator or accelerator that is championing and fueling the growth of Houston startups.
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support budding entrepreneurs.
  • Trailblazer, honoring an innovator who's made a lasting impact on the Houston innovation community.

Nominations may be made on behalf of yourself, your organization, and other leaders in the local innovation scene. The nomination period closes on August 31, so don't delay — nominate today at this link, or fill out the embedded form below.

Our panel of esteemed judges will review the nominations, and determine the finalists and winners. Finalists will be unveiled on September 30, and the 2025 Houston Innovation Awards winners will be announced live at our event on November 5.

Tickets will go on sale this fall. Stay tuned for that announcement, as well as more fanfare leading up to the 2025 Houston Innovation Awards.

Nominate now:

Interested in Innovation Awards sponsorship opportunities? Please contact sales@innovationmap.com.

MD Anderson launches $10M collaboration to advance personalized cancer treatment tech

fighting cancer

The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have announced a strategic collaboration to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.

The technology will be used as a tool for personalized cancer treatments and drug screening efforts, according to a release from MD Anderson. TOPPAN has committed $10 million over five years to advance the joint research activities.

“The strategic alliance with MD Anderson paves a promising path toward personalized cancer medicine," Hiroshi Asada, head of the Business Innovation Center at TOPPAN Holdings, said in a news release.

Invivoid is capable of establishing organoid models directly from patient biopsies or other tissues in a way that is faster and more efficient. Researchers may be able to test a variety of potential treatments in the laboratory to understand which approach may work best for the patient, if validated clinically.

“Organoids allow us to model the three-dimensional complexity of human cancers in the lab, thus allowing us to engineer a powerful translational engine—one that could not only predict how patients will respond to therapy before treatment begins but also could help to reimagine how we discover and validate next-generation therapies," Dr. Donna Hansel, division head of pathology and laboratory medicine at MD Anderson, added in the news release. “Through this collaboration, we hope to make meaningful progress in modeling cancer biology for therapeutic innovation.”

The collaboration will build upon preclinical research previously conducted by MD Anderson and TOPPAN. The organizations will work collaboratively to obtain College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certifications for the technology, which demonstrate a commitment to high-quality patient care. Once the certifications are obtained, they plan to conduct observational clinical studies and then prospective clinical studies.

“We believe our proprietary invivoid 3D cell culture technology, by enabling the rapid establishment of organoid models directly from patient biopsies, has strong potential to help identify more effective treatment options and reduce the likelihood of unnecessary therapies,” Asada added in the release. “Through collaboration on CAP/CLIA certification and clinical validation, we aim to bring this innovation closer to real-world patient care and contribute meaningfully to the advancement of cancer medicine."